glp-1 agonists cardiovascular diseases in Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Current Insights, Advantages and Challenges
Description
Are other dual-agonists in development as effective, and what factors (e.g., tolerability profile) may allow for competitive differentiation
Coupling of Gs and Gq in beta cells of pancreas lead to an increase in cAMP by activation of adenylyl cyclase and phosphoinositol 3 kinase (PI3K) pathway
Additionally, obesity contributes to joint and musculoskeletal disorders 6 , mental health challenges 7 , and a heightened risk of various cancers 8
GLP-1RA, glucagon like peptide-1 receptor agonist
In the tables below, the drugs are organized according to other factors that may be important in guiding treatment decisions
